NCT06147349 is a clinical trial of Radical or partial nephrectomy in Renal Cancer, sponsored by IRCCS San Raffaele.

Who is sponsoring NCT06147349?

NCT06147349 is sponsored by IRCCS San Raffaele.

What drugs are being tested in NCT06147349?

Interventions in NCT06147349: Radical or partial nephrectomy.

What condition does NCT06147349 study?

NCT06147349 studies Renal Cancer.

Is NCT06147349 still recruiting?

NCT06147349 is currently recruiting now. Last updated 27 November 2023.

Last reviewed 2023-11-27 · How we verify

NCT06147349

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kidney Cancer Observational Protocol

Recruiting now Last updated 27 November 2023

What this trial tests

trial testing Radical or partial nephrectomy in Renal Cancer in 2,500 participants. Currently enrolling.

Timeline

27 January 2010

Primary endpoint
4 February 2028

4 February 2028

Quick facts

Lead sponsor	IRCCS San Raffaele
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,500
Start date	27 January 2010
Primary completion	4 February 2028
Estimated completion	4 February 2028
Sites	1 location across Italy

Drugs / interventions tested

Radical or partial nephrectomy

Conditions studied

Renal Cancer — all drugs for Renal Cancer →

Sponsor

IRCCS San Raffaele — full company profile →

Who can join

18 and older, any sex, with Renal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study is to gather pre and post surgery clinical data belonging to patients who underwent radical or partial nephrectomy and to evaluate the impact of the surgery on the quality of life of the patients, as well as possible relapses within a 10 year period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer Patients.
Trevisani F, Floris M, Trepiccione F, Rosiello G, et al · · 2024 · cited 4× · PMID 39518690 · DOI 10.3390/jcm13216551

Verify or expand the search:

Other recruiting trials for Renal Cancer

Currently open trials in the same condition.

NCT07227415 — Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica · Phase 1, PHASE2 · recruiting
NCT07037589 — Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? · recruiting
NCT06967961 — Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers · NA · recruiting
NCT07141225 — Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy · NA · recruiting
NCT07303725 — Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology · recruiting

Other IRCCS San Raffaele trials

Trials by the same sponsor.

NCT07454759 — Acute Sarcopenia in Hospitalized Older Adults · not yet recruiting
NCT07456462 — Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance · NA · not yet recruiting
NCT07066878 — This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life B · not yet recruiting
NCT07526298 — Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Ap · not yet recruiting
NCT07426471 — Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections. · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06147349 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS San Raffaele
Last refreshed: 27 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06147349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing